Open AccessLong-term use of 0.003% tacrolimus suspension for treatment of vernal keratoconjunctivitis
Author(s) -
Abdulrahman Alamri,
SandraFlavia Fiorentini,
MaanA Albarry,
Ashjan Bamahfouz
Publication year - 2017
Publication title -
oman journal of ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.306
H-Index - 16
eISSN - 0974-7842
pISSN - 0974-620X
DOI - 10.4103/ojo.ojo_232_2014
Subject(s) - vernal keratoconjunctivitis , medicine , tacrolimus , term (time) , suspension (topology) , dermatology , ophthalmology , transplantation , physics , mathematics , quantum mechanics , homotopy , pure mathematics
To evaluate the safety and efficacy of 0.003% tacrolimus suspension for the treatment of refractory vernal keratoconjunctivitis (VKC).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom